SE0201922D0 - Koagulationshindrande komposition (Anticoagulant Composition) - Google Patents

Koagulationshindrande komposition (Anticoagulant Composition)

Info

Publication number
SE0201922D0
SE0201922D0 SE0201922A SE0201922A SE0201922D0 SE 0201922 D0 SE0201922 D0 SE 0201922D0 SE 0201922 A SE0201922 A SE 0201922A SE 0201922 A SE0201922 A SE 0201922A SE 0201922 D0 SE0201922 D0 SE 0201922D0
Authority
SE
Sweden
Prior art keywords
tablet
composition
heparin
polar lipids
anticoagulant composition
Prior art date
Application number
SE0201922A
Other languages
English (en)
Inventor
Bengt Hersloef
Per Tingvall
Original Assignee
Ltp Lipid Technologies Provide
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ltp Lipid Technologies Provide filed Critical Ltp Lipid Technologies Provide
Priority to SE0201922A priority Critical patent/SE0201922D0/sv
Publication of SE0201922D0 publication Critical patent/SE0201922D0/sv
Priority to EP03733728A priority patent/EP1542705B8/en
Priority to DE60315676T priority patent/DE60315676T2/de
Priority to PCT/SE2003/000973 priority patent/WO2004000332A1/en
Priority to DK03733728T priority patent/DK1542705T3/da
Priority to AU2003239011A priority patent/AU2003239011A1/en
Priority to ES03733728T priority patent/ES2291645T3/es
Priority to PT03733728T priority patent/PT1542705E/pt
Priority to AT03733728T priority patent/ATE369865T1/de
Priority to US10/516,858 priority patent/US7202087B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
SE0201922A 2002-06-20 2002-06-20 Koagulationshindrande komposition (Anticoagulant Composition) SE0201922D0 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE0201922A SE0201922D0 (sv) 2002-06-20 2002-06-20 Koagulationshindrande komposition (Anticoagulant Composition)
EP03733728A EP1542705B8 (en) 2002-06-20 2003-06-12 Anticoagulant composition
DE60315676T DE60315676T2 (de) 2002-06-20 2003-06-12 Gerinnungshemmende zusammensetzung
PCT/SE2003/000973 WO2004000332A1 (en) 2002-06-20 2003-06-12 Anticoagulant composition
DK03733728T DK1542705T3 (da) 2002-06-20 2003-06-12 Antikoagulerende sammensætning
AU2003239011A AU2003239011A1 (en) 2002-06-20 2003-06-12 Anticoagulant composition
ES03733728T ES2291645T3 (es) 2002-06-20 2003-06-12 Composicion anticoagulante.
PT03733728T PT1542705E (pt) 2002-06-20 2003-06-12 Ciclo-hexil(alquil)-propanolaminas, sua preparação e composições farmacêuticas que as contêm
AT03733728T ATE369865T1 (de) 2002-06-20 2003-06-12 Gerinnungshemmende zusammensetzung
US10/516,858 US7202087B2 (en) 2002-06-20 2003-06-12 Anticoagulant composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0201922A SE0201922D0 (sv) 2002-06-20 2002-06-20 Koagulationshindrande komposition (Anticoagulant Composition)

Publications (1)

Publication Number Publication Date
SE0201922D0 true SE0201922D0 (sv) 2002-06-20

Family

ID=20288280

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0201922A SE0201922D0 (sv) 2002-06-20 2002-06-20 Koagulationshindrande komposition (Anticoagulant Composition)

Country Status (10)

Country Link
US (1) US7202087B2 (sv)
EP (1) EP1542705B8 (sv)
AT (1) ATE369865T1 (sv)
AU (1) AU2003239011A1 (sv)
DE (1) DE60315676T2 (sv)
DK (1) DK1542705T3 (sv)
ES (1) ES2291645T3 (sv)
PT (1) PT1542705E (sv)
SE (1) SE0201922D0 (sv)
WO (1) WO2004000332A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10456327B2 (en) 2015-08-28 2019-10-29 Craig Robertson Package for frozen nutrient pill
WO2018185302A1 (en) * 2017-04-07 2018-10-11 Syddansk Universitet Moulding and casting of composites

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082667A (en) * 1988-06-07 1992-01-21 Abbott Laboratories Solid pharmaceutical dosage in tablet triturate form and method of producing same
NZ231281A (en) * 1988-11-08 1991-01-29 Takeda Chemical Industries Ltd Sustained release pharmaceutical preparations comprising the active agent dispersed in a solid matrix of a fatty acid ester of a polyglycerol
SE9003100D0 (sv) * 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system
US5665379A (en) * 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
SE9200951D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical composition containing a defined lipid system
ES2158084T3 (es) * 1994-02-04 2001-09-01 Lipocore Holding Ab Preparaciones vehiculo lipofilicas.
GB9719182D0 (en) * 1997-09-09 1997-11-12 Boc Group Plc Guide wire introducer
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
DE10026699A1 (de) * 2000-05-30 2001-12-06 Basf Ag Formulierung auf Heparin-, Glycosaminoglycan- oder Heparinoidbasis und Verwendung der Formulierung sowie der Formulierungsgrundlage
PT1349541E (pt) 2000-12-14 2007-01-31 Hoffmann La Roche Matriz lipídica auto-emulsionante (selm)
ITMI20012599A1 (it) 2001-12-11 2003-06-11 Cosmo Spa Composizioni farmaceutiche per la somministrazione orale di eparina osuoi derivati, utili per la terapia di malattie infiammatorie dell'int
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning

Also Published As

Publication number Publication date
DE60315676T2 (de) 2008-06-05
EP1542705A1 (en) 2005-06-22
US20060165780A1 (en) 2006-07-27
ATE369865T1 (de) 2007-09-15
DE60315676D1 (de) 2007-09-27
PT1542705E (pt) 2007-11-09
WO2004000332A1 (en) 2003-12-31
EP1542705B8 (en) 2007-10-10
EP1542705B1 (en) 2007-08-15
US7202087B2 (en) 2007-04-10
DK1542705T3 (da) 2007-11-26
ES2291645T3 (es) 2008-03-01
AU2003239011A1 (en) 2004-01-06

Similar Documents

Publication Publication Date Title
DK1576970T3 (da) Intraluminal indretning med en coating, der indeholder et terapeutisk middel
JO2481B1 (en) Silo cano-indol compounds have fluoride substitution and formulations containing such compounds and their treatment methods
MXPA05013824A (es) Inhibidores de quinasa p38 basados en heterociclos de 5 miembros.
ES2192213T3 (es) Arilalquil-diazinonas como inhibidores de fosfodiesterasa iv.
IL173203A0 (en) Novel cyano thiazolides, methods for the production thereof, and use thereof as a medicament
SG151271A1 (en) Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
ATE286660T1 (de) Zusammensetzungen mit essbaren ölen oder fetten und darin aufgelösten phytosterolen und/oder phytostanolen
ECSP055844A (es) Nuevos compuestos triciclicos
PT1000033E (pt) Derivados heterociclicos que inibem o factor xa
DE69031656D1 (de) Saccharinderivate zur verwendung als proteolytische enzyminhibitoren sowie verfahren zur herstellung
PT1082321E (pt) Derivados heterociclicos que inibem o factor xa
ES2190535T3 (es) Composiciones de lectina y uso de las mismas.
WO2003059875A3 (en) DERIVATIVES OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXY-CARBOXYLIC ACIDS USEFUL FOR THE TREATMENT OF DISEASES RESPONDING TO PPARα ACTIVATION
GB9809349D0 (en) Heterocyclic derivatives
DE60327511D1 (de) Zusammensetzung zur oralen oder rektalen verabreichung
SE0201922D0 (sv) Koagulationshindrande komposition (Anticoagulant Composition)
ATE488226T1 (de) Mahonia aquifolium extrakt, extraktionsverfahren und diesen enthaltende pharmazeutische zusammensetzung
ATE178207T1 (de) Verwendung von 2-(2-nitro-4- trifluormethylbenzoyl)-1,3-cyclohexandion zur behandlung von tyrosinämie sowie pharmazeutische zusammensetzungen
AR034920A1 (es) Metodos para el tratamiento de enfermedades intestinales inflamatorias
DE602005010256D1 (de) Produkt pflanzlichen ursprungs, das proanthocyane enthält, sowie verfahren zu seiner herstellung
PT746551E (pt) Acidos 4-aril-2-hidroxitetronicos opticamente puros
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.
HRP20050790A2 (en) New combinations and new use of selected pharmaceutically active compounds
DE50105577D1 (de) Ribavirin-granulat zur herstellung von filmtabletten
MY140954A (en) Composition for oral or rectal administration